Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacteriophages, or phages, are viruses that specifically infect and replicate within bacterial hosts [1]. They are the most abundant biological entities on Earth and play a fundamental role in maintaining microbial balance in various environments, including the human body [2]. In clinical applications, lytic phages are utilized as therapeutic agents—a practice known as phage therapy—to combat bacterial infections, particularly those caused by multi-drug resistant (MDR) pathogens [1, 4]. The therapeutic process involves the phage recognizing specific receptors on the bacterial cell surface, injecting its genetic material, and hijacking the host's machinery to produce new virions [3]. This process ultimately leads to the enzymatic lysis and death of the bacterium, releasing new phages to infect adjacent cells [3]. Unlike traditional antibiotics, phages are highly specific to their target bacterial species or strains, which helps preserve the host's commensal microbiome [1]. However, their use faces challenges such as the potential for rapid bacterial resistance and the release of pro-inflammatory endotoxins during bacterial lysis [3, 4]. Additionally, the narrow host range of phages often necessitates the development of personalized phage cocktails to match the specific infecting strain [4]. Despite these challenges, phages represent a promising alternative or adjunct to conventional antibiotics in the face of rising antimicrobial resistance [1].
Lytic cycle: adsorption to bacterial surface receptors, injection of viral DNA/RNA, replication of viral components, and enzymatic lysis of the bacterial cell wall via endolysins and holins [1, 3].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacteriophage (Phage).